Spectral AI (NASDAQ: MDAI) Q1 2026 revenue falls 40% as BARDA work shifts
Spectral AI reported a 40.5% decrease in Q1 2026 research and development revenue, totaling $3.99 million, primarily due to a slowdown in BARDA contract activities as the base phase neared completion. Despite the revenue decline, the company saw an improvement in gross margin to 50.8%. Spectral AI posted a net loss of $3.41 million for the quarter, a significant shift from a net income in the prior year, attributed to lower revenue and a $1.0 million warrant liability loss, alongside increased interest and debt-discount amortization.
MAR 24·ChartMill▲
Spectral AI Inc. (NASDAQ:MDAI) Reports Q4 Revenue Beat but Wider Loss, Stock Gains on Strong Cash Position
Spectral AI Inc. (NASDAQ:MDAI) released its Q4 2025 financial results, reporting a revenue beat of $3.85 million against an estimate of $2.98 million, but a wider non-GAAP loss per share of $0.11. Despite the loss, the stock saw gains in after-hours trading, driven by the revenue beat and a significantly strengthened cash position of $15.4 million. The company's focus remains on regulatory progress for its DeepView® System and its BARDA contract, with management providing a confident revenue guidance of $18.5 million for 2026, surpassing analyst estimates.
NOV 19·Benzinga▲
DeepView™ System Featured at 2025 US Burn Conferences - Spectral AI ( NASDAQ:MDAIW ) , Spectral AI ( NASDAQ:MDAI )
DALLAS, Nov. 19, 2025 ( GLOBE NEWSWIRE ) -- Spectral AI, Inc. ( NASDAQ:MDAI ) ( "Spectral AI" or the "Company" ) , an artificial intelligence ( AI ) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced its prominent role at the ...
